Selection and Application of DNA Aptamer Against Oncogene Amplified in Breast Cancer 1

Journal of Molecular Evolution

Volumn 81, Issue 5-6, 2015, Pages 179-185

  An, Yuan ^a   Wu, Jie ^a   Yang, Bo ^b   Zhu, Zhi ^a   Gao, Mingxuan ^a   Yu, Chundong ^b   Yang, Chaoyong James ^a  

^a XIAMEN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

AIB1; Aptamer; Cancer; SELEX

Indexed keywords

APTAMER; HISTONE ACETYLTRANSFERASE PCAF; NCOA3 PROTEIN, HUMAN; PROTEIN BINDING; STEROID RECEPTOR COACTIVATOR 3;

HEK293 CELL LINE; HUMAN; METABOLISM; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE;

APTAMERS, NUCLEOTIDE; HEK293 CELLS; HUMANS; NUCLEAR RECEPTOR COACTIVATOR 3; P300-CBP TRANSCRIPTION FACTORS; PROTEIN BINDING; SELEX APTAMER TECHNIQUE;

EID: 84948387460     PISSN: 00222844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00239-015-9703-y     Document Type: Article

References (35)

1. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965–968
2. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569–580
3. Fang X, Tan W (2010) Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res 43:48–57
4. Guan XY, Meltzer PS, Dalton WS, Trent JM (1994) Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat Genet 8:155–161
5. Hu J, Wu J, Li C, Zhu L, Zhang WY, Kong G, Lu Z, Yang CJ (2011) A G-quadruplex aptamer inhibits the phosphatase activity of oncogenic protein Shp2 in vitro. ChemBioChem 12:424–430
6. Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45:1628–1650
7. Kishimoto H, Wang Z, Bhat-Nakshatri P, Chang D, Clarke R, Nakshatri H (2005) The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12. Carcinogenesis 26:1706–1715
8. Li J, O’Malley BW, Wong J (2000) p300 requires its histone acetyltransferase activity and SRC-1 interaction domain to facilitate thyroid hormone receptor activation in chromatin. Mol Cell Biol 20:2031–2042
9. Liao L, Kuang SQ, Yuan Y, Gonzalez SM, O’Malley BW, Xu J (2002) Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1. J Steroid Biochem Mol Biol 83:3–14
10. Litterst CM, Pfitzner E (2001) Transcriptional activation by STAT6 requires the direct interaction with NCoA-1. J Biol Chem 276:45713–45721
11. Liu Z, Wong J, Tsai SY, Tsai MJ, O’Malley BW (1999) Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin. Proc Natl Acad Sci USA 96:9485–9490
12. Liu Z, Wong J, Tsai SY, Tsai MJ, O’Malley BW (2001) Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin. Proc Natl Acad Sci USA 98:12426–12431
13. Long W, Yi P, Amazit L, LaMarca HL, Ashcroft F, Kumar R, Mancini MA, Tsai SY, Tsai MJ, O’Malley BW (2010) SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration. Mol Cell 37:321–332
14. Long W, Foulds CE, Qin J, Liu J, Ding C, Lonard DM, Solis LM, Wistuba II, Tsai SY, Tsai MJ et al (2012) ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. J Clin Invest 122:1869–1880
15. Louie MC, Zou JX, Rabinovich A, Chen HW (2004) ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol Cell Biol 24:5157–5171
16. Mo P, Zhou Q, Guan L, Wang Y, Wang W, Miao M, Tong Z, Li M, Majaz S, Liu Y et al (2015) Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling. Oncogene 34:3935–3945
17. Nutiu R, Li Y (2005) In vitro selection of structure-switching signaling aptamers. Angew Chem Int Ed Engl 44:1061–1065
18. Osborne SE, Ellington AD (1997) Nucleic acid selection and the challenge of combinatorial chemistry. Chem Rev 97:349–370
19. Planas-Silva MD, Shang Y, Donaher JL, Brown M, Weinberg RA (2001) AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res 61:3858–3862
20. Rosenberg JE, Bambury RM, Van Allen EM, Drabkin HA, Lara PN Jr, Harzstark AL, Wagle N, Figlin RA, Smith GW, Garraway LA et al (2014) A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma. Invest New Drugs 32:178–187
21. Shangguan D, Tang Z, Mallikaratchy P, Xiao Z, Tan W (2007) Optimization and modifications of aptamers selected from live cancer cell lines. ChemBioChem 8:603–606
22. Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ (2008) The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res 68:2358–2365
23. Suen CS, Berrodin TJ, Mastroeni R, Cheskis BJ, Lyttle CR, Frail DE (1998) A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity. J Biol Chem 273:27645–27653
24. Tien JC, Xu J (2012) Steroid receptor coactivator-3 as a potential molecular target for cancer therapy. Expert Opin Ther Targets 16:1085–1096
25. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510
26. Voegel JJ, Heine MJ, Tini M, Vivat V, Chambon P, Gronemeyer H (1998) The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J 17:507–519
27. Wilson DS, Szostak JW (1999) In vitro selection of functional nucleic acids. Annu Rev Biochem 68:611–647
28. Wu RC, Qin J, Hashimoto Y, Wong J, Xu J, Tsai SY, Tsai MJ, O’Malley BW (2002) Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase. Mol Cell Biol 22:3549–3561
29. Wu C, Yan L, Wang C, Lin H, Chen X, Yang CJ (2010) A general excimer signaling approach for aptamer sensors. Biosens Bioelectron 25:2232–2237
30. Xie D, Sham J, Zeng WF, Lin HL, Bi J, Che LH et al (2005) Correlation of AIB1 over-expression with advanced clinical stage of human colorectal carcinoma. Hum Pathol 36:777–783
31. Xu Y, Chen Q, Li W, Su X, Chen T, Liu Y, Zhao Y, Yu C (2010) Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness. Oncogene 29:3386–3397
32. Yan AC, Bell KM, Breeden MM, Ellington AD (2005) Aptamers: prospects in therapeutics and biomedicine. Front Biosci 10:1802–1827
33. Yan J, Tsai SY, Tsai MJ (2006a) SRC-3/AIB1: transcriptional coactivator in oncogenesis. Acta Pharmacol Sin 27:387–394
34. Yan J, Yu CT, Ozen M, Ittmann M, Tsai SY, Tsai MJ (2006b) Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Cancer Res 66:11039–11046
35. Zhou HJ, Yan J, Luo W, Ayala G, Lin SH, Erdem H, Ittmann M, Tsai SY, Tsai MJ (2005) SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res 65:7976–7983